BIOTHERAPIES PAVILION

PARTICIPANT SPOTLIGHT

Versiti Inc Q&A

2025 Biotherapies Pavilion Participant Spotlight: Versiti

AABB interviewed Nichole Miller, MSTM, SBB(ASCP), senior director of biomaterial operations at Versiti, a participating organization in the Biotherapies Pavilion at the 2025 AABB Annual Meeting. Read the interview below to learn more about the Versiti team.

Tell us a bit about yourself. What is your name? Where are you from? What is your role at Versiti and how long have you been part of the team?

My name is Nichole Miller, MSTM, SBB(ASCP); I am the senior director of biomaterials operations for Versiti and Versiti Clinical Trial Services. I have held multiple roles throughout my 17-year career at Versiti with increasing scope and complexity, including research technologist at Versiti's Blood Research Institute, innovation and technical specialist for production and distribution in blood services, donor management supervisor, specialized production manager and director, and chief of staff.

In my current role, I drive operational excellence in providing high-quality biomaterials for research, further manufacturing, and clinical development. I am also the organizational official for Salus IRB, an independent review board that specializes in single and multi-site oncology, device, drug, and social, behavioral and educational research review services. I completed my specialist in blood banking certification in 2014, master's degree in transfusion medicine in 2018 and Harvard Business School's executive education program for leadership development in 2023.

What are your most important goals as a company for this year and next? What are you most excited to see develop?

One of Versiti's core goals is to deepen our expertise and broaden our services in autologous and allogeneic cellular staring materials, enabled manufacturing, and storing and distributing biotherapies. The cell therapy space is very dynamic and, as a blood collection facility, we are uniquely positioned to be a strategic partner for researchers, manufacturers and developers all along the production pathway. I am most excited about unlocking Versiti's potential as a supplier and enabled manufacturer of biotherapies.

Nichole Miller

"AABB has been a tremendous resource in helping Versiti navigate its path forward in biotherapies."

Versiti will be participating in the Biotherapies Pavilion for the third year in a row. How would you describe AABB's role in helping companies such as yours continue to advance within the biotherapies field?

AABB has been a tremendous resource in helping Versiti navigate its path forward in biotherapies. My current two favorite resources are Standards for Cellular Therapy Services and Getting Started in Processing for Biotherapies. These resources have been very helpful in understanding the current thinking and requirements needed to move forward in this space. In addition, AABB’s Certified Advanced Biotherapies Professional (CABP) certification program has elevated several key Versiti team members' knowledge in cell therapy.

Versiti has several Certified Advanced Biotherapies Professionals (CABPs) on your team now. Can you tell us a bit more about who they are and their different roles in the organization?

A few key members of our team have earned their CABP:

  • Jessica Drouillard, MSTM, SBB, CABP - vice president and chief quality officer
  • Adam Young, MS, CABP - laboratory scientist, cell therapy lab
  • Sorelle Jefcik, RN, BSN, QIA, NE-BC, CABP - apheresis and cell therapy program development manager

Become a Certificated Advanced Biotherapies Professional (CABP)

Becoming a CABP is a mark of distinction, establishing that qualified professionals have demonstrated – through a certification exam – that they have the necessary knowledge to credibly practice in the field of biotherapies.

Learn More

AABB Biotherapies Lab

Why was it important to encourage staff members to pursue the CABP? What does that mean for Versiti and how would you say it has impacted how your teams work day-to-day, as well as how they will continue to improve and collaborate in the future?

It is really exciting to have these three individuals with CABPs working at Versiti and bringing their expertise to critical pillars of cell therapy. Jessica highlights her knowledge gained through the CABP program by providing guidance around regulations and strategy to our executive team and throughout Versiti's regulatory team for cell therapy. Adam handles tissue products, including autologous and allogeneic apheresis products, along with bone marrow and cord blood. The process of studying for the exam allowed him to expand his knowledge base and opportunities within the organization. He believes the required CE allows him to maintain a working knowledge of different advances in the field beyond what he'd be exposed to in his day-to-day. Sorelle leads the nursing team at Versiti who handle autologous cell therapy collections and provides hope and amazing care for patients during their collections.

Quote Icon

"I am looking forward to the energetic, passionate and educational environment that focuses on improving and innovating the blood banking, biotherapy and cell therapy field."

Is there anything else you would like to share ahead of your participation at the Biotherapies Pavilion? What are you most looking forward to at the 2025 AABB Annual Meeting in San Diego this year?

I am looking forward to the energetic, passionate and educational environment that focuses on improving and innovating the blood banking, biotherapy and cell therapy field. I am also looking forward to making connections and developing partnerships with those looking to enhance their offerings in the cell therapy space.

BIOTHERAPIES PAVILION AT THE AABB ANNUAL MEETING

INQUIRE ABOUT 2025 OPPORTUNITIES

Register your interest in biotherapies sponsorship and connection packages at the 2025 Annual Meeting, taking place October 25-28, in San Diego, CA.

Inquire Now